About Hippo Dx
Hippo Dx is a company based in Belgium founded in 2020 by Wim Hofkens and Peter Deroovere. Hippo Dx has raised $4.67 million across 2 funding rounds from investors including AllerFund, LRM and imec.istart. The company has 6 employees as of December 31, 2022. Hippo Dx offers products and services including S.P.A.T.. Hippo Dx operates in a competitive market with competitors including SetPoint Medical, Boomerang Medical, Therakos, Labseed and TheraLight, among others.
- Headquarter Belgium
- Employees 6 as on 31 Dec, 2022
- Founders Wim Hofkens, Peter Deroovere
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hippocreates
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.67 M (USD)
in 2 rounds
-
Latest Funding Round
$4.61 M (USD), Series A
Oct 04, 2023
-
Investors
AllerFund
& 2 more
-
Employee Count
6
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hippo Dx
Hippo Dx offers a comprehensive portfolio of products and services, including S.P.A.T..
Automated tool for performing skin prick tests in allergy diagnosis.
Funding Insights of Hippo Dx
Hippo Dx has successfully raised a total of $4.67M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.61 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Hippo Dx
Hippo Dx has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include AllerFund, LRM and imec.istart.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are focused on food allergy solutions.
|
Locked | Locked | Locked | |
|
LRM is engaged in providing risk capital and smart money to businesses in Limburg.
|
Locked | Locked | Locked | |
|
Funding solutions for tech startups are provided by the accelerator.
|
Locked | Locked | Locked |
Investor details for Hippo Dx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hippo Dx
Investment portfolio details for Hippo Dx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hippo Dx
Detailed financials for Hippo Dx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hippo Dx Comparisons
Peer comparison for Hippo Dx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hippo Dx
Hippo Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SetPoint Medical, Boomerang Medical, Therakos, Labseed and TheraLight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable neuromodulation devices are developed for inflammatory diseases.
|
|
| Locked | Locked | Locked |
Bioelectronic devices are developed for autoimmune disease treatment.
|
|
| Locked | Locked | Locked |
Therakos is focused on photopheresis systems for CTCL treatment.
|
|
| Locked | Locked | Locked |
Technology to suppress capsular contraction is developed.
|
|
| Locked | Locked | Locked |
Provides red light therapy beds to promote cellular health and reduce oxidative stress.
|
Detailed competitors of Hippo Dx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hippo Dx
Complete news archive for Hippo Dx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hippo Dx
Hippo Dx was founded in 2020.
Hippo Dx is headquartered in Belgium.
Hippo Dx is a funded company, having raised a total of $4.67M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Hippo Dx is 6.
Developer of a medical device to provide an automated test that detects allergies. It offers S.P.A.T. that assists doctors and medical personnel in the diagnosis and treatment of chronic conditions and pathologies based on robotics and artificial intelligence technologies.
Hippo Dx's top competitors include SetPoint Medical, Boomerang Medical and Therakos.
Hippo Dx offers S.P.A.T..
Hippo Dx has 3 investors. Key investors include AllerFund, LRM, and imec.istart.